a coagulant for hemophiliacs INTENDED TO USE IN THE MIDDLE OF THE DECADE in Argentina 1980Vendían infected with AIDS remedy According to research from The New York Times, followed a laboratory sold in countries of Latin America and Asia although it was known that infect Bogdanich and Eric Koli hemofílicos.Walt THE NEW YORK TIMES. SPECIAL
CLARIN mid 80's, laboratory division of Bayer sold millions of dollars from a product-coagulant for hemophiliacs that carried a high risk of transmitting the AIDS virus, in Asia and Latin America, including Argentina, while in developed countries sold a new and more insurance, according to documents to which he agreed to The New York Times.La Bayer unit, Cutter Biological, introduced its safer medicine in late February 1984, when there was sufficient evidence that the previous version infecting hemophiliacs with HIV. However, for over a year, the company continued to sell the older product in exterior.Según records show the intention of Cutter executives was to get rid of a large stock of a product marketed increasingly less in the U.S. and Europe. However, after starting to sell the new product, the company continued to produce the previous version for several months. A telex from Cutter to a distributor suggests one reason behind that decision: the company had several contracts at a specified price and believed to produce the earlier version of the medication will be less costoso.Casi 20 years later, it is virtually impossible to document the amount of human victims of these business decisions. At this point, and disappeared various medical records and is difficult to pinpoint when foreign hemophiliacs were infected with HIV before Cutter began selling its safer medicine or after-.Sólo in Hong Kong and Taiwan, more than 100 hemophiliacs were infected with HIV after use the original version of Cutter, according to records and interviews. Many have died since then. Cutter also continued to sell the product after February 1984 in Malaysia, Singapore, Indonesia, Japan and Argentina. Bayer Disclaimer
a statement, Bayer said that Cutter had "behaved responsibly, ethically and humanely" in selling the old product overseas. According to statement, Cutter had continued to sell their original medication because some customers doubted the effectiveness of new drugs and because some countries were slow to approve its sale. The company also said that a shortage of plasma, used to manufacture the product, Cutter had prevented him making more doses of the new product.The product, called Factor VIII, provides the missing ingredient without which hemophiliacs' blood can not clot . To inject the medication, hemophiliacs stop bleeding or prevent bleeding before it occurs. Some use it about three times a week and allows them to lead a life normal.Pero in the early years of the AIDS epidemic, Factor VIII was lethal was manufactured from plasma of more than 10,000 donors and as yet there was no test for the AIDS virus, it carried a high risk of disease transmission. In the United States, AIDS was transmitted to thousands of hemophiliacs, many of whom died, one of the worst medical disasters in history linked to drugs. While not admitting any guilt, Bayer and three workshops that made the concentrate were paid hemophiliacs about $ 600 million to end more than 15 years of lawsuits legales.Los Cutter documents, internal memos, minutes of meetings marketing of the company and letters to distributors foreign-Cutter reveal the decision to continue exporting the older product after started producing the new version, which through heat treatment killed the show VIH.ComplicidadSegún documents, U.S. federal regulators helped the overseas sales do not come to light. In May 1985, the regulator of such products within the Food and Drug Administration of USA (the body responsible for approving the sale of new drugs and food), Harry Meyer Jr., summoned the companies involved and said that it was unacceptable to continue sending this material to exterior.Pero Meyer asked that the issue "is solved quietly, without alerting Congress, the medical community and the public, "according to records of the meeting Cutter 1985.Cuando a distributor of Hong Kong, in late 1984, expressed an interest in the new product, Cutter asked to" exhaust the stock "of the former, and assured him that there was" no serious risk. "TRANSLATION OF CLAUDIA GISELA MARTINEZ
OSTROVSKY DIED OF AIDS TO 22 years.This tragic case of the hemophiliac whose girlfriend died of HIV The young man was treated with factor VIII and was infected with AIDS. In 1991 the parents of the girl began a lengthy trial to determine whether there was negligence médica.Sibila contagion Camps THE DRAFTING OF CLARIN
The HIV infection in hemophiliacs through contaminated blood plasma concentrates, also came to court in Argentina. The lawsuit was filed by the parents of a young woman who died of AIDS in 1989 after catching her boyfriend hemophiliac, asymptomatic carriers of the virus. Three doctors were prosecuted in this case, and finally dismissed as definitiva.Cuando died, Gisela Ostrovsky was 22 and studying medicine. In 1985 he started a relationship with a boy, who never concealed that it was severe hemophilia. For that reason attending the Hematological Research Institute of the National Academy Medicine, and received concentrates with factor VIII blood plasma coagulante.Los girl's parents, Nelida Piana and Moses Ostrovsky, promoted the complaint in June 1991 with the intention of knowing whether the contamination was intentional and, if so, whether had been liability on the part of professionals and / or authorities of the Institute and Gisela Academia.El boyfriend knew he was infected with HIV in December 1985 but the judge said the doctor who treated him, he only said "the existence of the virus and nothing else." The girl was to inform the Institute where, as recalled his parents told him "the boy was not sick." In a new query partner, "it explained what was going on" and "did not tell them the dangers of that fact and the precautions they should take," the boy said in his statement. Gisela began to suspect he had AIDS in April 1987 and confirmed shortly thereafter. By then, of 237 hemophiliacs who had undergone an HIV test, 128 were already infected. Among them, 89 had symptoms of enfermedad.En contrast, the National Academy of Medicine said that "HIV-positive patients were informed personally of the meaning of the test result, and the measures to be implemented to prevent transmission of the disease." In December 1994, Judge Mariano Berges prosecuted doctors Miguel de Tezanos Pinto, Raúl Pérez Bianco and Armando Anselmo. The case, labeled a malicious infection, had taken a new momentum following the presentation of a woman who had lost her husband and son with hemophilia because of medical sida.Los replied Giselle's boyfriend had been submitted to blood collection for HIV on July 9, 1985, at the Institute of Hematologic Research, but had not returned until July 1987. "The law on AIDS said that if the patient is not satisfied to get the test result, we must cite a letter, but not send mail diagnosis," recalled Perez Bianco. Still, it was enacted only in 1989. "As for the other case, the hematologist said the woman was pregnant in November 1985, and her husband had been diagnosed with AIDS in June 1986, but was infected from 1983.El April 19, 1996, the judge issued Bergés dismissal of the three doctors, the release expressly disclaims any liability in the infections. The decision was appealed by the complainants and finally, on March 10, 1997, the Board VI Criminal Appeals upheld the decision of juez.El Gisela ex boyfriend lives and continues his treatment. In August 1999 was tabled in the House of Representatives a project for the state to compensate with 100,000 pesos to each infected hemophiliac. Never treated.
0 comments:
Post a Comment